Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 37,868 | 39,553 | 42,011 | 35,985 | 37,441 |
| Cost of Goods | 6,586 | 6,067 | 9,119 | 8,811 | 8,653 |
| Gross Profit | 31,282 | 33,486 | 32,892 | 27,174 | 28,788 |
| Operating Expenses | 38,300 | 43,107 | 38,716 | 35,663 | 35,823 |
| Operating Income | -6,432 | -9,555 | -5,705 | -7,677 | -6,382 |
| Interest Expense | 606 | 668 | 586 | 98 | 264 |
| Other Income | 572 | 3,938 | 710 | 2,213 | 75 |
| Pre-tax Income | -6,466 | -6,285 | -5,581 | -5,562 | -6,570 |
| Income Tax | -23 | 46 | 69 | 35 | 56 |
| Net Income Continuous | -6,444 | -6,331 | -5,650 | -5,597 | -6,626 |
| Net Income Discontinuous | N/A | N/A | N/A | 1,994 | 3,207 |
| Minority Interests | 36 | -51 | -80 | -95 | -80 |
| Net Income | $-6,480 | $-6,279 | $-5,570 | $-3,508 | $-3,339 |
| EPS Basic Total Ops | -0.46 | -0.44 | -0.38 | -0.24 | -0.22 |
| EPS Basic Continuous Ops | -0.46 | -0.44 | -0.39 | -0.37 | -0.43 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.13 | 0.21 |
| EPS Diluted Total Ops | -0.46 | -0.44 | -0.38 | -0.24 | -0.22 |
| EPS Diluted Continuous Ops | -0.46 | -0.44 | -0.39 | -0.37 | -0.43 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.13 | 0.21 |
| EPS Diluted Before Non-Recurring Items | -0.09 | 0.14 | 0.11 | -0.01 | -0.06 |
| EBITDA(a) | $-1,530 | $-1,275 | $-377 | $-3,071 | $-1,633 |